| Pharmaceutical Intermediates | Manufacturing complex intermediates for antipsychotic, antiviral, and specialty pharmaceutical molecules. | Proprietary advanced chemical synthesis capabilities, multiple chemistry expertise, and strong client relationships. | B2B focus serving global pharma companies in regulated markets including EU and US. | Specialty chemicals and patented molecule intermediates with strong technical barriers. | 108 | 100 | Sales to pharmaceutical companies on contract and supply basis. | Contract manufacturing with negotiated pricing based on volume and complexity. | Demand for complex intermediates, regulatory compliance, R&D innovation, and expanded manufacturing capacity. | |
